---
created: 2025-04-13
updated: 2025-04-13T10:51
id: mA:pIK|Z8-
specialty: patho
specialty_id: 108
tags:
  - source/ak-original-decks::step-1::zanki-step-decks::zanki-immunology-+-general-pathology::pathoma-chapter-3-(neoplasia)
  - source/ak-step1-v11::
  - theme/firstaid::04-pathology::03-neoplasia::08-oncogenes
  - source/ak-step1-v11::
  - theme/firstaid::04-pathology::03-neoplasia::08-oncogenes::signal-transducers::bcr-abl
  - source/ak-step1-v11::
  - theme/firstaid::10-hematology-oncology::04-pathology::28-leukemia::acute-leukemia::acute-lymphoblastic-leukemia::b-all
  - source/ak-step1-v11::
  - theme/firstaid::10-hematology-oncology::04-pathology::29-chronic-myeloproliferative-disorders
  - source/ak-step1-v11::
  - theme/firstaid::10-hematology-oncology::04-pathology::29-chronic-myeloproliferative-disorders::chronic-myelogenous-leukemia
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::13-hematology-oncology::18-myeloproliferative-disorders
  - source/ak-step1-v11::
  - theme/pathoma::03-neoplasia::02-carcinogenesis::2-oncogenes
  - source/ak-step1-v11::
  - theme/pathoma::03-neoplasia::02-carcinogenesis::2-oncogenes::table-3.3-important-oncogenes::signal-transducers
  - source/ak-step1-v11::
  - theme/pathoma::03-neoplasia-alt-tagging::bluegalaxies::02-carcinogenesis::2-oncogenes
  - source/ak-step1-v11::
  - theme/pathoma::03-neoplasia-alt-tagging::bluegalaxies::02-carcinogenesis::2-oncogenes::signal-transducers
  - source/ak-step1-v11::
  - theme/physeo::11-pathology::07-general-pathology::09-carcinogenesis
  - source/ak-step1-v11::
  - theme/physeo::11-pathology::10-hemeonc-pathology::14-myeloproliferative-disorders
  - source/ak-step1-v11::
  - theme/pixorize::01-immunology::07-leukemias-&-lymphomas::03-cml
  - source/ak-step1-v11::
  - theme/pixorize::02-biochem::22-onc-drugs::18-imatinib,-dasatinib
  - source/ak-step1-v11::
  - theme/sketchypath::10-myeloid-&-lymphoid::01-myeloid-disorders::01-myeloproliferative-neoplasms-&-myelodysplastic-syndromes
  - source/ak-step1-v11::
  - theme/sketchypath::10-myeloid-&-lymphoid::01-myeloid-disorders::02-acute-myeloid-leukemia-(aml)-&-chronic-myeloid-leukemia-(cml)
  - source/ak-step1-v11::
  - theme/uworld::1000-9999::8000-8999::8281
  - source/ak-step1-v11::
  - theme/uworld::10000-99999::12000-12999::12278
  - source/ak-step1-v11::^other::^expn::bgadd
  - source/ak-step1-v11::^other::^fa-updates::fa2018"
type: flashcard
---

# Question
Translocations of the ABL proto-oncogene with the Breakpoint Cluster Region (BCR) = BCR-ABL1 fusion gene = on chromosome **22** are associated with:   - **CML = Chronic Myelogenous** Leukemia - **adult ALL = Acute Lymphoblastic** Leukemia

---

# Answer
- adult ALL = POOR prognosis  - the resultant fusion protein (BCR-ABL) can be treated with Imatinib / Dasatinib (specifically designed to inhibit this fusion protein) BCR-ABL = the resulting fusion gene of t(9;22) encodes a protein with inc tyrosine kinase activity that inhibits apoptosis while promoting mitogenesis